文献速递牙体牙髓病牙周病

锂掺杂生物玻璃45S5用于常见口腔疾病潜在治疗的研究

Li-doped bioglass® 45S5 for potential treatment of prevalent oral diseases.
PubMed 文献 · J Dent · 2020-12-29

本研究通过溶胶-凝胶法合成纯生物玻璃BG和掺杂5-wt%锂的BGLi,评估其对体外脱矿人牙釉质的再矿化及对龋齿和牙周炎相关菌株的抗菌行为。结果显示BG和BGLi均使釉质病变部分再矿化,显微硬度恢复约45%,并抑制变异链球菌和牙龈卟啉单胞菌生长;BGLi对伴放线放线杆菌的抑制浓度低于BG。结论认为生物玻璃可用于龋病和牙周炎治疗,锂的存在不影响生物活性并增强对伴放线放线杆菌的抗菌效果。

要点

  • BG和BGLi均使体外脱矿釉质部分再矿化,显微硬度恢复约45%。
  • BG和BGLi分别在50和200 mg/mL浓度下抑制变异链球菌和牙龈卟啉单胞菌生长。
  • BGLi对伴放线放线杆菌的抑制浓度为20 mg/mL,低于BG的100 mg/mL。

核心结论

  • 生物玻璃可用于龋病和牙周炎治疗,促进牙齿再矿化并杀灭主要病原菌。
  • 锂的存在不影响生物玻璃的生物活性,并提高对伴放线放线杆菌的抗菌效果。

研究设计与样本

  • 采用溶胶-凝胶法合成Bioglass® 45S5(BG)和掺杂5-wt% Li的BGLi。
  • 使用体外脱矿人牙釉质进行再矿化测试,通过扫描电镜(SEM)和维氏显微硬度(HV)评估。
  • 抗菌行为评估针对变异链球菌、伴放线放线杆菌和牙龈卟啉单胞菌。

主要发现

  • BG和BGLi应用于釉质表面后,釉质病变部分再矿化,显微硬度恢复约45%。
  • BG和BGLi分别在50和200 mg/mL浓度下抑制变异链球菌和牙龈卟啉单胞菌生长。
  • BGLi对伴放线放线杆菌的抑制浓度为20 mg/mL,BG为100 mg/mL。

关键数值与推荐

  • 再矿化效果以维氏显微硬度恢复约45%为指标。
  • 抗菌抑制浓度:变异链球菌50 mg/mL,牙龈卟啉单胞菌200 mg/mL。
  • 伴放线放线杆菌抑制浓度:BGLi为20 mg/mL,BG为100 mg/mL。

临床怎么用

  • 生物玻璃颗粒可能作为龋病和牙周炎的辅助治疗手段,兼具再矿化和抗菌作用。
  • 锂掺杂生物玻璃可能增强对伴放线放线杆菌的抗菌效果,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Despite the excellent properties of both pure bioglasses (BG) and BG doped with therapeutic ions (such as Li) in hard tissue applications, there is not enough information about their role in the remineralization and bacterial-growth in oral diseases. The aim of this contribution is to evaluate the effect of both pure BG and BG doped with 5-wt% of Li (BGLi) on both the remineralization of in vitro demineralized human-teeth and the antimicrobial behavior against strains from caries and periodontitis. METHODS: Bioglass® 45S5 (BG) and BGLi were synthesized by the sol-gel method. The remineralization tests were carried out using in vitro demineralized enamel teeth and evaluated by Electron Microscopy (SEM) and Vickers micro-hardness (HV). The antimicrobial behavior of the particles was evaluated against S. mutans, A. actinomycetemcomitans, and P. gingivalis, representing pathogens from caries and periodontitis. RESULTS: Enamel lesion was partially remineralized when both bioglasses (BG and BGLi) were applied on its surface with micro-hardness recoveries around 45 %. They further inhibited the growth of S. mutans and P. gingivalis, at 50 and 200 mg/mL, respectively. BGLi presented a higher toxicity against A. actinomycetemcomitans than BG, with inhibition concentrations of 20 mg/mL and 100 mg/mL, respectively. CONCLUSIONS: Bioglasses could be used in the treatment of two of the most prevalent oral diseases: caries and periodontitis, promoting the remineralization of the teeth and killing the main pathogens. The presence of Li did not affect the bioactivity of the bioglass and improved the antibacterial effect over A. actinomycetemcomitans strain.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Palza Cordero H, Castro Cid R, Diaz Dosque M, et al. Li-doped bioglass® 45S5 for potential treatment of prevalent oral diseases. J Dent. 2020. PMID: 33385532. doi:10.1016/j.jdent.2020.103575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。